Recently it was shown that MID1, by inhibiting PP2A, also positively modulates inflammatory pathways through the activation of NFκB [8], a crucial oncogenic factor [9] pivotal for metastasis of PCa [10]. This evidence concerns the gene MID1 and posterior cortical atrophy.